US-based XingImaging LLC and China-based Mitro Biotech Co., Ltd have announced a partnership to provide contract research services in China. The collaboration aims to partner with global pharma and biotech companies in the target market, focusing on neuroscience and oncology.
XingImaging: Specializing in Radiotracer Production and PET Acquisition
XingImaging, based in Connecticut, specializes in radiotracer production through Positron Emission Tomography (PET) acquisition to evaluate biomarkers and support the development of treatments for neurodegenerative disorders, including Alzheimer’s and Parkinson’s diseases, as well as oncology and other disease pathologies. The firm previously supported Japanese firm Eisai in carrying out Alzheimer’s disease studies in China, a deal announced in 2018.
Mitro Biotech: Providing Comprehensive Contract Research Services
Mitro Biotech, founded in 2012, aims to provide pre-clinical and clinical contract research services using molecular imaging technologies. The firm also offers translational research services from mice, rats, and monkeys to humans, with a focus on disease areas such as cancer, coronary heart disease, Alzheimer’s disease, epilepsy, Parkinson’s disease, rheumatoid arthritis, diabetes, gene expression, stem cell research, and others.-Fineline Info & Tech
